CG Oncology, Inc. (CGON) Profit Margins
Over the twelve months to 2026-06-30, CG Oncology, Inc. (CGON) had operating margin -4056.2%, net margin -3602.7%, free cash flow margin -2879.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGONCG Oncology, Inc.Follow CGON — free
—
Price chart with a free account
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | — | — | -15.0% | — | |
| Operating margin | -27180.9% | -10067.3% | -4722.1% | -4056.2% | |
| Net margin | -23827.0% | -7729.5% | -3985.0% | -3602.7% | |
| FCF margin | — | -6931.3% | -3279.2% | -2879.6% |
USD billions · SEC XBRL
CG Oncology, Inc. — questions
- What is CG Oncology, Inc.'s operating margin?
- -4056.2% over the twelve months to 2026-06-30.
- What is CG Oncology, Inc.'s net profit margin?
- -3602.7% over the twelve months to 2026-06-30.
Every figure on this page comes from CG Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.